In vitro effects of recombinant human growth hormone on growth of human gastric cancer cell line BGC823 cells

Table 4 Percentages of BGC823 cells in various phases of cell cycle (n = 3, mean ± SD)

Group	G0–G1(%)	S (%)	G2–M(%)
I	47.75 ± 0.78	36.95 ± 0.49	15.25 ± 0.21
II	83.85 ± 1.77b	7.85 ± 0.64b	8.30 ± 1.13b
IIIa	53.03 ± 4.31	32.17 ± 7.47	14.73 ± 3.40
IIIb	52.33 ± 4.55	32.63 ± 6.19	14.73 ± 1.88
IIIc	52.33 ± 4.94	33.50 ± 8.17	14.17 ± 3.29
IIId	51.27 ± 5.94	33.67 ± 8.89	15.07 ± 3.07
IVa	85.07 ± 2.62b	6.67 ± 3.88b	8.00 ± 1.82b
IVb	86.47 ± 2.07b	5.47 ± 1.88b	7.77 ± 0.40b
IVc	85.53 ± 0.47b	7.87 ± 4.99b	6.37 ± 5.61b
IVd	86.13 ± 2.87b	4.20 ± 1.61b	9.67 ± 1.27b

^bP<0.01 vs control group or rhGH group.